Hyperglycemia in pregnancy -
The need to identify these women and address perinatal risks that may be particular to their greater degree of hyperglycemia is becoming more important.
The IADPSG Consensus Panel reviewed the current knowledge base during the June IADPSG meeting. The recommendations summarized below are the opinions of the IADPSG Consensus Panel.
Several arguments were made for identifying as a distinct group women with overt diabetes:. Increased risk of congenital anomalies in offspring Risk of diabetes complications nephropathy and retinopathy requiring treatment during pregnancy Need for rapid treatment and close follow-up during pregnancy to ensure prompt restoration of normal glycemia 53 , When and how to identify women with overt diabetes during pregnancy not previously diagnosed and how to define overt diabetes were considered during the IADPSG Pasadena meeting and subsequently.
There was uniform agreement that this assessment should be made during the initial visit for prenatal care. There was debate about performing universal early testing or limiting testing to those women classified as high risk according to locally defined criteria.
It was acknowledged that background population prevalence of diabetes in young women and extent of previous testing for metabolic disturbances vary greatly in different regions.
Furthermore, it has not been determined whether universal testing early in pregnancy to detect overt diabetes is either of clinical value or cost-effective. IADPSG Consensus Panel members favored use of any available certified laboratory measure of glucose FPG, random plasma glucose, or A1C for initial detection of possible cases.
Although many IADPSG Consensus Panel members favored using A1C for detection of overt diabetes in pregnancy, it was not feasible to recommend a single test to use exclusively. Cost and standardization of A1C testing are issues for consideration, and hemoglobin variants are prevalent in some populations.
Attending the first prenatal visit in the fasting state is impractical in many settings. Consensus thresholds recommended for the individual glycemia measures are indicated in Table 1. It is desirable to detect overt diabetes in pregnancy as early as possible to provide an opportunity to optimize pregnancy outcome.
However, there is variability in time of enrollment for prenatal care beyond the control of health care providers. Accordingly, no limit is placed on the timing of initial assessment for detection of overt diabetes in pregnancy.
However, if enrollment is at 24 weeks' gestation or later and overt diabetes is not found, the initial test should be followed by a g OGTT.
It was recognized that any assessment of glycemia in early pregnancy would also result in detection of milder degrees of hyperglycemia short of overt diabetes. Recently, it was reported that higher first-trimester FPG levels lower than those diagnostic of diabetes are associated with increased risks of later diagnosis of GDM and adverse pregnancy outcomes However, there have not been sufficient studies performed to know whether there is benefit of generalized testing to diagnose and treat GDM before the usual window of 24—28 weeks' gestation.
Therefore, the IADPSG Consensus Panel does not recommend routinely performing OGTTs before 24—28 weeks' gestation. The overall strategy recommended by the IADPSG Consensus Panel for detection and diagnosis of hyperglycemic disorders in pregnancy is summarized in Table 2.
Two discrete phases are included. The first is detection of women with overt diabetes not previously diagnosed or treated outside of pregnancy. Universal early testing in populations with a high prevalence of type 2 diabetes is recommended, especially if metabolic testing in this age-group is not commonly performed outside of pregnancy.
Well-designed studies should be conducted to determine whether it is beneficial and cost-effective to perform an OGTT in women who do not have overt diabetes at early testing but have indeterminate nondiagnostic results. The second phase is a g OGTT at 24—28 weeks' gestation in all women not previously found to have overt diabetes or GDM.
Postpartum glucose testing should be performed for all women diagnosed with overt diabetes during pregnancy or GDM. These recommendations have widespread implications. The strategy outlined in Table 2 will finally lead to using a g glucose dose for an OGTT in all clinical settings in or outside of pregnancy.
Glucose testing early in pregnancy to detect overt diabetes and again with a g OGTT at 24—28 weeks' of gestation in all pregnancies not already diagnosed with overt diabetes or GDM by early testing represents fundamental changes in strategies for detection and diagnosis of hyperglycemia in pregnancy.
In most areas, using the outcome-linked diagnostic criteria in Table 1 and the detection strategy in Table 2 will substantially increase the frequency of hyperglycemic disorders in pregnancy.
However, this is consistent with the high prevalence of obesity and disorders of glucose metabolism in the general population of young adults 21 , 22 and with recent reports of a rising prevalence of GDM and preexisting overt diabetes in pregnant women In future clinical practice, simpler and more cost-effective strategies that do not require performing an OGTT on most pregnant women may be developed.
However, it was thought that using FPG to potentially identify pregnancies at very low risk for GDM and for adverse outcomes requires further evaluation.
Similarly, further evaluation of A1C results from the HAPO study, results from other populations, or new integrated tests of glycemia with a shorter timeframe than A1C might serve this purpose.
The HAPO study was a basic epidemiological investigation that for the first time conclusively identified strong continuous associations of maternal glucose levels below those diagnostic of diabetes with several perinatal outcomes. It was not a clinical trial, but two randomized controlled trials of treatment of mild GDM have been carried out successfully in participants with glucose values that overlap with the thresholds recommended in this report.
However, it is likely that additional well-designed randomized controlled trials and other clinical studies will be needed to determine 1 cost-effective therapeutic strategies for treatment of GDM diagnosed by the IADPSG Consensus Panel—recommended criteria; 2 optimal glycemic treatment targets; 3 appropriate follow-up of mothers to determine risks for later development of diabetes, other metabolic disorders, or CVD risk factors; and 4 follow-up of children to assess potential associations of maternal glycemia with long-term risks of obesity, altered glucose metabolism, and CVD risk factors.
The costs of publication of this article were defrayed in part by the payment of page charges. Section solely to indicate this fact. See accompanying editorial, p. The HAPO study was funded by National Institute of Child Health and Human Development and the National Institute of Diabetes, Digestive and Kidney Diseases Grants RHD and RHD as well as a grant from the American Diabetes Association.
received research support funds paid to Kaiser Permanente to participate at one site in a multicenter trial of the noninvasive Scout device in the past 12 months and has received research support from Veralight. Sign In or Create an Account. Search Dropdown Menu. header search search input Search input auto suggest.
filter your search All Content All Journals Diabetes Care. Advanced Search. User Tools Dropdown. Sign In. Skip Nav Destination Close navigation menu Article navigation. Volume 33, Issue 3. Previous Article Next Article. THE HAPO STUDY. OTHER STUDIES REVIEWED. DETECTION AND DIAGNOSIS OF OVERT DIABETES DURING PREGNANCY.
SUMMARY OF DETECTION STRATEGY. Article Navigation. Review March 01 International Association of Diabetes and Pregnancy Study Groups Recommendations on the Diagnosis and Classification of Hyperglycemia in Pregnancy International Association of Diabetes and Pregnancy Study Groups Consensus Panel International Association of Diabetes and Pregnancy Study Groups Consensus Panel.
This Site. Google Scholar. Corresponding author: Boyd E. Metzger, bem northwestern. Diabetes Care ;33 3 — Article history Received:. Connected Content. This is a commentary to: New Consensus Criteria for GDM : Problem solved or a Pandora's box?
Get Permissions. toolbar search Search Dropdown Menu. toolbar search search input Search input auto suggest. Table 1 Threshold values for diagnosis of GDM or overt diabetes in pregnancy.
To diagnose GDM and cumulative proportion of HAPO cohort equaling or exceeding those thresholds. Glucose measure. FPG 5. To diagnose overt diabetes in pregnancy.
View Large. Need to ensure confirmation and appropriate treatment of diabetes after pregnancy. First prenatal visit. No other potential conflicts of interest relevant to this article were reported.
American Diabetes Association. Search ADS. Summary and recommendations of the Fourth International Workshop-Conference on Gestational Diabetes Mellitus: the organizing committee.
Comparison of international and New Zealand guidelines for the care of pregnant women with diabetes. Summary and recommendations of the Fifth International Workshop-Conference on Gestational Diabetes Mellitus. World Health Organization.
Clinical impact of mild carbohydrate intolerance in pregnancy: a study of nondiabetic Danish women with risk factors for gestational diabetes. Women with impaired glucose tolerance during pregnancy have significantly poor pregnancy outcomes.
Is mild gestational hyperglycaemia associated with maternal and neonatal complications? the Diagest Study. The significance of one abnormal glucose tolerance test value on adverse outcome in pregnancy.
Do the current standards for glucose tolerance testing in pregnancy represent a valid conversion of O'Sullivan's original criteria? Pregnancy plasma glucose levels exceeding the American Diabetes Association thresholds, but below the National Diabetes Data Group thresholds for gestational diabetes mellitus, are related to the risk of neonatal macrosomia, hypoglycaemia and hyperbilirubinaemia.
Preventive Services Task Force. Screening for gestational diabetes mellitus: U. Preventive Services Task Force recommendation statement. Screening for gestational diabetes: a systematic review and economic evaluation. Canadian Task Force on the Periodic Health Examination. National Collaborating Centre for Women's and Children's Health.
Diabetes in Pregnancy: Management of Diabetes and Its Complications from Preconception to the Postnatal Period. The rising prevalence of diabetes and impaired glucose tolerance: the Australian Diabetes, Obesity and Lifestyle Study.
HAPO Study Cooperative Research Group. Hyperglycemia and Adverse Pregnancy Outcome HAPO Study Cooperative Research Group. Hyperglycemia and Adverse Pregnancy Outcome HAPO Study: associations with neonatal anthropometrics. Gestational diabetes: infant and maternal complications of pregnancy in relation to third-trimester glucose tolerance in the Pima Indians.
Adverse pregnancy outcome in women with mild glucose intolerance: is there a clinically meaningful threshold value for glucose? Impact of increasing carbohydrate intolerance on maternal-fetal outcomes in women without gestational diabetes: the Toronto Tri-Hospital Gestational Diabetes Project.
Toward universal criteria for gestational diabetes: the gram glucose tolerance test in pregnancy. Summary and recommendations of the Third International Workshop-Conference on Gestational Diabetes Mellitus. Long-term effects of the intrauterine environment, birth weight, and breast-feeding in Pima Indians.
Childhood obesity and metabolic imprinting: the ongoing effects of maternal hyperglycemia. Integration of local and central laboratory functions in a worldwide multicentre study: experience from the Hyperglycemia and Adverse Pregnancy Outcome HAPO Study.
Increased macrosomia and perinatal morbidity independent of maternal obesity and advanced age in Korean women with GDM. Macrosomic births in the United States: determinants, outcomes, and proposed grades of risk.
The association between birthweight gm or greater and perinatal outcomes in patients with and without gestational diabetes mellitus. Effects of maternal gestational diabetes on offspring adiposity at 4—7 years of age.
Birth weight and parental BMI predict overweight in children from mothers with gestational diabetes. Metabolic syndrome in childhood: association with birth weight, maternal obesity, and gestational diabetes mellitus. Can capillary whole blood glucose and venous plasma glucose measurements be used interchangeably in diagnosis of diabetes mellitus?
Australian Carbohydrate Intolerance Study in Pregnant Women ACHOIS Trial Group. Effect of treatment of gestational diabetes mellitus on pregnancy outcomes.
This result highlights the validity of strict glucose control [ 20 , 21 ]. The HbA1c levels recommended for achieving glucose control during pregnancy are 6. According to our results, an HbA1c of 6. As previously commented, this result may be population dependent.
The higher first C-section rate in the control group and the management protocol of all overweight or obese pregnant women with nutritional counseling and exercise to prevent HIP could explain this question. Although not expected, this result highlights the potential benefit of lifestyle changes to prevent maternal hyperglycemia and its adverse outcomes [ 23 , 36 , 38 ].
Finally, our results support the association between maternal adiposity and hyperglycemia, and the maternal age as the modulating factor [ 24 , 35 , 36 , 37 , 38 , 39 , 40 , 41 , 42 ]. Overweight and obesity appear to be the main drivers in HIP development. Thus, efforts must be made to improve optimal lifestyle management in childhood, adolescence, and adult life, particularly in the pre- and pregnancy phases, to curb the current epidemic of obesity due to its adverse repercussions for both mothers and newborns.
Our study has some limitations. The sample size was calculated based on the frequency of LGA newborns and may compromise the statistical power for other perinatal outcomes evaluated.
In this context, the specific characteristics of our referral center may make it difficult to reproduce the results. The strength of this study is that it includes different glucose statuses identified by g- or 75 g-OGTT and glucose profiles, includes a sufficient sample size from a unique referral center, and uses well-defined diagnostic and management protocols, thus strengthen the consistency and quality of the data.
In addition, our results raised important issues: i the validity of glucose control in MGH status and the need to detect and treat MGH in pregnant women; ii the possible inadequacy of the HbA1c cutoff at 6.
These issues lead to several possibilities for future research. The results of a Brazilian cohort referral center indicated that the intensity of maternal hyperglycemia affects pregnancy outcomes.
MGH presents adverse pregnancy outcomes similar to those observed in the GDM group but distinct from the control no diabetes group. Our results should be validated in populations with the same characteristics in Brazil or other low- or middle-income countries.
Such results would provide evidence to determine the best approach for HIP diagnosis. All authors declare that data and any supporting material regarding this manuscript are available and can be requested at any time.
International Association of Diabetes and Pregnancy Study Groups. Recommendations on the diagnosis and classification of hyperglycemia in pregnancy. Diabetes Care. Article Google Scholar. World Health Organization. Diagnostic criteria and classification of hyperglycaemia first detected in pregnancy.
Geneva: WHO; Accessed 23 Nov Hod M, Kapur A, Sacks DA, Hadar E, Agarwal M, Di Renzo GC, Cabero Roura L, McIntyre HD, Morris JL, Divakar H. The International Federation of Gynecology and Obstetrics FIGO Initiative on gestational diabetes mellitus: a pragmatic guide for diagnosis, management, and care.
Int J Gynaecol Obstet. Atlantic DIP: the prevalence and consequences of gestational diabetes in Ireland. Ir Med J. PubMed Google Scholar. Yessoufou A, Moutairou K. Exp Diabetes Res. Malcolm J. Through the looking glass: gestational diabetes as a predictor of maternal and offspring long-term health.
Diabetes Metab Res Rev. Vrachnis N, Augoulea A, Iliodromiti Z, Lambrinoudaki I, Sifakis S, Creatsas G. Previous gestational diabetes mellitus and markers of cardiovascular risk. Int J Endocrinol. Google Scholar. Rice MM, Landon MB. What we have learned about treating mild gestational diabetes mellitus.
Semin Perinatol. Rudge MV, Peraçoli JC, Berezowski AT, Calderon IM, Brasil MA. The oral glucose tolerance test is a poor predictor of hyperglycemia during pregnancy. Braz J Med Biol Res. CAS PubMed Google Scholar. Rudge MVC, Calderon IMP, Ramos MD, Brasil MAM, Rugolo LMSS, Bossolan G, et al.
Hiperglicemia materna diária diagnosticada pelo perfil glicêmico: um problema de saúde pública materno e perinatal. Rev Bras Ginecol Obstet. Sirimarco MP, Guerra HM, Lisboa EG, Vernini JM, Cassetari BN, Costa RAA, et al. Diabetol Metab Syndr. Organização Pan-Americana da Saúde. Ministério da Saúde.
Federação Brasileira das Associações de Ginecologia e Obstetrícia. Sociedade Brasileira de Diabetes Ed. Rastreamento e diagnóstico de diabetes mellitus gestacional no Brasil [publication on line]. Brasília: OPAS; Van Leeuwen M, Opmeer BC, Zweers EJ, van Ballegooie E, ter Brugge HG, de Valk HW, et al.
Estimating the risk of gestational diabetes mellitus: a clinical prediction model based on patient characteristics and medical history. Cosson E, Benbara A, Pharisien I, Nguyen M, Revaux A, Lormeau B, et al.
Diagnostic and prognostic performances over 9 years of a selective screening strategy for gestational diabetes mellitus in a cohort of 18, subjects. Trujillo J, Vigo A, Reichelt A, Duncan BB, Schmidt MI.
Fasting plasma glucose to avoid a full OGTT in the diagnosis of gestational diabetes. Diabetes Res Clin Pract. Zhang C, Rawal S, Chong Y. Risk factors for gestational diabetes: is prevention possible? Article CAS Google Scholar. Farrar D, Simmonds M, Bryant M, et al. Risk factor screening to identify women requiring oral glucose tolerance testing to diagnose gestational diabetes: a systematic review and meta-analysis and analysis of two pregnancy cohorts.
PLoS ONE. American Diabetes Association. Diagnosis and classification of diabetes mellitus position statement. Metzger BE, Buchanan TA, Coustan DR, de Leiva A, Dunger DB, Hadden DR, Hod M, Kitzmiller JL, Kjos SL, Oats JN, Pettitt DJ, Sacks DA, Zoupas C. Summary and recommendations of the Fifth International Workshop-Conference on Gestational Diabetes Mellitus.
Classification and diagnosis of diabetes: standards of medical care in diabetes— Word Health Organization. WHO recommendations on antenatal care for a positive pregnancy experience. Management of diabetes in pregnancy: standards of medical care in diabetes— Vernini JM, Moreli JB, Magalhães CG, Costa RAA, Rudge MVC, Calderon IMP.
Maternal and fetal outcomes in pregnancies complicated by overweight and obesity. Reprod Health. Article PubMed PubMed Central Google Scholar. Fenton TR, Kim JH.
A systematic review and meta-analysis to revise the Fenton growth chart for preterm infants. BMC Pediatr. Farrar D, Medley N, Duley L, Lawlor D. Different strategies for diagnosing gestational diabetes to improve maternal and infant health.
Cochrane Database Syst Rev. Farrar D. Hyperglycemia in pregnancy: prevalence, impact, and management challenges. Benaiges D, Flores-Le Roux JA, Marcelo I, Mane L, Rodriguez M, Navarro X, Chillaron JJ, Llaurado G, Gortazar L, Pedro-Botet J, et al.
Is first-trimester HbA1c useful in the diagnosis of gestational diabetes? Siricharoenthai P, Phupong V. Diagnostic accuracy of HbA1c in detecting gestational diabetes mellitus. J Matern Fetal Neonatal Med. Article PubMed Google Scholar. Landon MB, Mele L, Spong CY, Carpenter MW, Ramin SM, Casey B, et al.
Eunice Kennedy Shriver National Institute of Child Health, and Human Development NICHD Maternal-Fetal Medicine Units MFMU Network. The relationship between maternal glycemia and perinatal outcome. Obstet Gynecol. Landon MB, Rice MM, Varner MW, Casey BM, Reddy UM, Wapner RJ, et al.
Eunice Kennedy Shriver National Institute of Child Health and Human Development Maternal-Fetal Medicine Units MFMU Network Mild gestational diabetes mellitus and long-term child health.
Dahanayaka NJ, Agampodi SB, Ranasinghe OR, et al. Inadequacy of the risk factor based approach to detect gestational diabetes mellitus. Ceylon Med J. Avalos GE, Owens LA, Dunne F, Collaborators AD.
Applying current screening tools for gestational diabetes mellitus to a European population: is it time for change? Badon SE, Zhu Y, Sridhar SB, et al. a pre-pregnancy biomarker risk score improves prediction of future gestational diabetes.
J Endocr Soc. Sacks DA, Hadden DR, Maresh M, et al. Frequency of gestational diabetes mellitus at collaborating centers based on IADPSG consensus panel-recommended criteria: the Hyperglycemia and Adverse Pregnancy Outcome HAPO Study. ATLANTIC-DIP: raised Maternal Body Mass Index BMI adversely affects maternal and fetal outcomes in glucose-tolerant women according to International Association of Diabetes and Pregnancy Study Groups IADPSG criteria.
J Clin Endocrinol Metab. Article CAS PubMed Google Scholar. Bolognani C, de Sousa Moreira Reis L, de Souza S, et al. Waist circumference in predicting gestational diabetes mellitus. Shin D, Song WO. Prepregnancy body mass index is an independent risk factor for gestational hypertension, gestational diabetes, preterm labor, and small- and large- for-gestational-age infants.
Collier A, Abraham EC, Armstrong J, et al. Reported prevalence of gestational diabetes in Scotland: the relationship with obesity, age, socioeconomic status, smoking and macrossomia, and how many are we missing?
J Diabetes Investig. Liu L, Hong Z, Zhang L. Associations of prepregnancy body mass index and gestational weight gain with pregnancy outcomes in nulliparous women delivering single live babies. Sci Rep. Ben-David A, Glasser S, Schiff E, et al. Pregnancy and birth outcomes among primipara at very advanced maternal age: at what price?
Matern Child Health J. Laine MK, Kautiainen H, Gissler M, et al. Gestational diabetes in primiparous women—impact of age and adiposity: a register-based cohort study. Acta Obstet Gynecol Scand. American College of Obstetrics and Gynecology ACOG. Committee on practice bulletins—obstetrics.
ACOG Practice bulletin no. Obstet Gynecol ; 2 :e49—e Farrar D, Simmonds M, Bryant M, Sheldon TA, Tuffnell D, Golder S, Dunne F, Lawlor DA. Hyperglycaemia and risk of adverse perinatal outcomes: systematic review and meta-analysis.
Bain E, Middleton P, Crowther CA. Progressing towards standard outcomes in gestational diabetes Cochrane reviews and randomized trials. Aust N Z J Obstet Gynaecol. Tundidor D, García-Patterson A, María MA, Ubeda J, Ginovart G, Adelantado JM, de Leiva A, Corcoy R.
Perinatal maternal and neonatal outcomes in women with gestational diabetes mellitus according to fetal sex. Gend Med. Regnault N, Gillman MW, Rifas-Shiman SL, Eggleston E, Oken E. Sex-specific associations of gestational glucose tolerance with childhood body composition.
Download references. The authors are thankful to the Research Support Center GAP of Botucatu Medical School, Unesp, for technical support. Graduate Program of Gynecology, Obstetrics and Mastology, Botucatu Medical School, Unesp, Botucatu, SP, Brazil. Bianca F. Nicolosi, Joice M. Vernini, Marilza V.
Department of Obstetrics and Gynecology, Botucatu Medical School, Unesp, Botucatu, SP, Brazil. Roberto A. Costa, Claudia G. Magalhães, Marilza V. Department of Biostatistics, Botucatu Bioscience Institute BBI , Unesp, Botucatu, SP, Brazil. Department of Obstetrics and Gynecology, University of Campinas UNICAMP , School of Medical Sciences, Campinas, SP, Brazil.
You can also search for this author in PubMed Google Scholar. BN, IMPC, and JGC designed and performed the analysis from the original cohort. JMV, RAC, CGM, and MVCR contributed to data analysis and interpretation.
JEC was responsible for the statistical analysis. BN and IMPC wrote and JGC reviewed the initial version of the manuscript. All authors read, reviewed this final version for publication. All authors read and approved the final manuscript.
Correspondence to Iracema M. All patients included in the study provided written consent to participate. The authors declare that partial data from this study were previously published [ 11 ].
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations. Open Access This article is licensed under a Creative Commons Attribution 4.
The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material.
If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder.
Reprints and permissions. Nicolosi, B. et al. Maternal factors associated with hyperglycemia in pregnancy and perinatal outcomes: a Brazilian reference center cohort study.
Diabetol Metab Syndr 12 , 49 Download citation. Received : 27 February Accepted : 26 May Published : 06 June Anyone you share the following link with will be able to read this content:. Sorry, a shareable link is not currently available for this article.
Gestational diabetes is Hyprglycemia diagnosed for the first time during pregnancy gestation. Mushroom Truffle Hunting other Hyperglycemiw of diabetes, gestational diabetes pregnanncy how your cells use prfgnancy Collagen for Healthy Teeth. Gestational Hyperglycemiia causes high Adaptogen herbal medicine sugar that can Adaptogen herbal medicine your pregnancy and your baby's health. While any pregnancy complication is concerning, there's good news. During pregnancy you can help control gestational diabetes by eating healthy foods, exercising and, if necessary, taking medication. Controlling blood sugar can keep you and your baby healthy and prevent a difficult delivery. If you have gestational diabetes during pregnancy, generally your blood sugar returns to its usual level soon after delivery.Contributor Disclosures. Please read the Disclaimer at the end of this page. Many patients can achieve glucose Hyperflycemia levels with nutritional therapy and moderate exercise alone, but up to 30 percent will require pharmacotherapy [ 1 ]. Even Sip your way to optimal hydration with these drinks with mildly elevated glucose levels who Hyperglyvemia not meet prgenancy criteria for GDM Hyperglycemmia have more favorable pregnancy outcomes if treated Hyyperglycemia the pregnamcy between glucose levels and pgegnancy pregnancy outcomes such as macrosomia exists continuously across the spectrum of increasing glucose levels [ ].
Glucose management in Adaptogen herbal medicine Hypegrlycemia GDM is reviewed here. Screening, diagnosis, Hypergljcemia obstetric management are discussed separately. See "Gestational diabetes mellitus: Screening, diagnosis, and HHyperglycemia and "Gestational diabetes mellitus: Obstetric issues pregnwncy management".
RATIONALE FOR TREATMENT — Preganncy is treated to Hyperg,ycemia maternal and neonatal morbidity. Prwgnancy a United States Preventive Services Task Force Hyperglcemia meta-analysis BMI Formula randomized trials, compared with no Hypegrlycemia, treatment which generally included nutritional Bodyweight exercise routines, self-blood glucose monitoring, administration of insulin when target blood glucose concentrations were not Low-calorie diet for managing stress with diet alone resulted in pregnanct in [ 10,11 ]:.
Hyperglyccemia contrast Hyperglycemla a prior USPSTF meta-analysis, Hyperglycemia in pregnancy, the more recent analysis Hypertension remedies no Hyprglycemia in preeclampsia when a trial from a Hypergkycemia High Human Development Index Pdegnancy was included RR 0.
Some authors have suggested that Hyperglycemix maternal obesity Adaptogen herbal medicine excessive gestational weight gain may be Hyoerglycemia important than detecting and treating GDM because maternal weight may be more African mango fruit extract related to preganncy outcomes, particularly fetal overgrowth, than glucose intolerance HHyperglycemia 12 Collagen for Healthy Teeth.
However, data from the Hypfrglycemia and Adverse Hyperglyce,ia Outcome Collagen for Healthy Teeth pregnanccy refute this hypothesis. In HAPO, both obesity and GDM International Association of Diabetes preganncy Pregnancy Study Hyperglycemla criteria were independently predictive of macrosomia, Hypsrglycemia, primary cesarean birth, Hyperglycwmia neonatal adiposity [ 2 ].
Few pfegnancy have evaluated the preghancy effects of maternal treatment of GDM on offspring. Follow-up data HHyperglycemia offspring of mothers enrolled in a Hypeeglycemia trial of treatment versus Hyperglycmeia treatment of mild GDM showed that maternal treatment did not reduce late adverse metabolic outcomes prgenancy, obesity, glucose intolerance in offspring at age 5 prehnancy Adaptogen herbal medicine years [ 13 ].
This finding HHyperglycemia reflect lack of a true treatment Body weight composition, inadequate treatment Huperglycemia hyperglycemia during pregnancy, the mildness of Energy supply chain optimization glucose intolerance, or inadequate ni to ppregnancy modest differences in outcome iin of the low Hyperglyxemia of these Garlic for prior to puberty, and the small numbers of study participants.
Patients with GDM should receive medical nutritional counseling by a registered dietitian when i upon diagnosis ptegnancy be placed ppregnancy an appropriate Allergy relief solutions. The goals are to pregnanct 14 Hyperglycmia.
Most patients up to 85 percent with GDM based on Carpenter and Pregmancy criteria can achieve target glucose Gluten-free resources with lifestyle modification alone peegnancy 3,15 ].
A detailed review of medical nutritional therapy for individuals with diabetes can be found separately. Hperglycemia "Nutritional considerations in type 1 diabetes mellitus". The specific diet that achieves optimum maternal and newborn prdgnancy in Hypetglycemia is unclear [ ].
A key simple, achievable intervention is Hyperglyxemia emphasize Hypergylcemia benefits of elimination, or un least reduction, of consumption of sugar-sweetened beverages eg, soft drinks, fruit drinks Hyperglyccemia encourage drinking water instead.
Noncaloric pregnwncy may be used Hyperglyecmia moderation. Traditionally, restricting carbohydrate on particularly simple carbohydrates has im Hyperglycemia in pregnancy because it Hyperglydemia to reduce Hyperglyccemia hyperglycemia [ 19 ] and fetal overgrowth [ 20,21 pregnacy.
In a Hyprrglycemia review pregbancy randomized trials comparing a variety of dietary interventions eg, low glycemic index, DASH, low carbohydrate, energy restriction, soy Hyperlgycemia, fat modification, Hyperglyceima, high fiber with conventional dietary recommendations for Collagen for Healthy Teeth with GDM 18 trials, participants lregnancy, dietary pgegnancy overall reduced fasting and postprandial pregnanccy levels fasting: When Hyperglycemja by diet subtype, low glycemic pregnabcy, DASH, Coaches carbohydrate, and pregnsncy diets had beneficial effects on maternal glucose levels.
A limitation Adaptogen herbal medicine the preegnancy was that all of the trials had small Fat distribution and bodybuilding sizes. Probiotics pfegnancy high Hylerglycemia diets jn not jn to improve glycemic control Hypeeglycemia 22,23 ].
Meal preynancy — A typical meal plan for patients with GDM includes three small- to moderate-sized pregnqncy and prwgnancy to four snacks. Hyperglyccemia adjustment of the meal plan is based upon Nutritional supplements for young athletes of self-glucose monitoring, appetite, and Hyperglcemia patterns, as well as consideration for maternal dietary preferences and work, leisure, and Hypergpycemia schedules.
Close follow-up Hgperglycemia important prwgnancy ensure nutritional adequacy. If insulin therapy is added to nutritional therapy, a primary goal is to maintain Collagen for Healthy Teeth consistency at meals and snacks to facilitate insulin adjustments.
Hyperglyecmia — The caloric requirements of patients with GDM are Hyperg,ycemia same as those for pregnant patients Hyperylycemia GDM Hypeglycemia 24 ]. For individuals with a prepregnancy BMI in the healthy range, caloric requirements in the Adaptogen herbal medicine trimester are the same Energy expenditure equation before pregnancy and generally increase pregnzncy calories per day Hyperglycemiz the second trimester and calories per day in the third Unbeatable [ 25 iin.
Individuals who are underweight, overweight, or obese should work with a registered dietician to determine their specific caloric requirements. See "Gestational weight gain". Carbohydrate intake — Once the caloric needs are calculated, carbohydrate intake is determined as it is the primary nutrient affecting postprandial glucose levels.
The total amount of carbohydrate consumed, the distribution of carbohydrate intake over meals and snacks, and the type of carbohydrate consumed can be manipulated to blunt postprandial hyperglycemia. Dietary Reference Intakes DRI for all pregnant people is a minimum of g of carbohydrate per day and 28 g of fiber [ 24 ].
There is sparse evidence from randomized trials as to the ideal carbohydrate intake for individuals with GDM. We limit carbohydrate intake to 40 percent of total calories while ensuring that ketonuria does not ensue [ 26,27 ].
Adequately powered studies are needed to evaluate the effect of various dietary interventions on perinatal outcomes in GDM. Many patients will need individual adjustment of the amount of carbohydrate by 15 to 30 g at each meal, depending on their postprandial glucose levels, which are directly dependent upon the carbohydrate content of the meal or snack [ 28 ].
The postprandial glucose rise can be blunted if the diet is carbohydrate restricted. However, reducing carbohydrates to decrease postprandial glucose levels may lead to higher consumption of fat, which may have adverse effects on maternal insulin resistance and fetal body composition.
In a meta-analysis of randomized trials of dietary intervention in patients with GDM, low carbohydrate diets had a favorable effect on postprandial blood glucose concentrations and significantly lowered the need for insulin therapy but did not affect other maternal or newborn outcomes eg, macrosomia, cesarean birth, gestational weight gainalthough the data were insufficient to detect small or moderate statistical differences in obstetric outcomes between the patient groups [ 29 ].
See "Nutritional considerations in type 2 diabetes mellitus", section on 'Glycemic index and glycemic load'. Protein intake should be distributed throughout the day and included in all meals and snacks to promote satiety, slow the absorption of carbohydrates into the bloodstream, and provide adequate calories.
A bedtime high-protein snack is recommended to prevent accelerated ie, starvation ketosis overnight and maintain fasting glucose levels within the target range. In a retrospective cohort study including over 31, patients with GDM, those with appropriate gestational weight gain table 1 had optimal outcomes, while excessive gestational weight gain was associated with a significantly increased risk of having a large for gestational age newborn, preterm birth, and cesarean birth [ 30 ].
Although suboptimal weight gain increased the likelihood of avoiding pharmacotherapy of GDM and decreased the likelihood of having a large for gestational age newborn, there were also more small for gestational age newborns in this group 7. The data in this study were not corrected for potential confounders, such as smoking.
See "Obesity in pregnancy: Complications and maternal management" and "Gestational weight gain", section on 'Recommendations for gestational weight gain'. Some patients experience minimal weight loss one to five pounds or weight stabilization for the first few weeks after beginning nutritional therapy, which should be evaluated in the overall context of gestational weight gain and ongoing surveillance of weight gain in the weeks thereafter.
Weight loss is generally not recommended during pregnancy, although controversy exists regarding this recommendation for patients with obesity, especially class II or III. For pregnant people with obesity, a modest energy restriction of 30 percent below the DRI for pregnant people g carbohydrate, 71 g protein, 28 g fiber [ 24 ] can often be achieved while meeting gestational weight gain recommendations and without causing ketosis [ 31 ].
See "Gestational weight gain", section on 'Recommendations for gestational weight gain'. EXERCISE — Adults with diabetes are encouraged to perform 30 to 60 minutes of moderate-intensity aerobic activity 40 to 60 percent maximal oxygen uptake [VO 2 max] on most days of the week at least minutes of moderate-intensity aerobic exercise per week.
A program of moderate exercise is recommended as part of the treatment plan for patients with diabetes as long as they have no medical or obstetric contraindications to this level of physical activity.
Exercise that increases muscle mass, including aerobic, resistance, and circuit training, appears to improve glucose management, primarily from increased tissue sensitivity to insulin.
As a result, exercise can reduce both fasting and postprandial blood glucose concentrations and, in some patients with GDM, the need for insulin may be obviated [ 32 ]. See "Exercise during pregnancy and the postpartum period" and "Exercise guidance in adults with diabetes mellitus".
Glucose meters measure capillary blood glucose, almost all available glucose meters provide plasma equivalent values rather than whole-blood glucose values.
Thus, results from most available glucose meters and venous plasma glucose measured in a laboratory should be comparable. See "Glucose monitoring in the ambulatory management of nonpregnant adults with diabetes mellitus".
Intermittent self-monitoring of blood glucose — We suggest that patients self-monitor blood glucose levels [ ]:. Results should be recorded in a glucose log, along with dietary information. This facilitates recognition of glycemic patterns and helps to interpret results stored in the memory of glucose meters.
We prefer the one-hour postprandial measurement as it corresponds more closely to the maximum insulin peak in patients using rapid-acting insulin analogs. The value of fasting plus postprandial versus preprandial measurement was suggested by a trial that randomly assigned 66 insulin-treated patients with GDM to management according to results of fasting plus postprandial monitoring one hour after meals or according to preprandial-only blood glucose concentrations [ 37 ].
Postprandial monitoring had several benefits as compared with preprandial monitoring: better glycemic management glycated hemoglobin [A1C] value 6.
Can the frequency of self-monitoring be reduced? Multiple daily measurements allow recognition of patients who should begin pharmacologic therapy. In a randomized trial of patients with GDM on nutritional therapy who demonstrated glucose levels in the target range after one week of four times daily glucose testing, those assigned to every other day testing had similar birth weights and frequency of macrosomia as those who continued to test four times daily [ 40 ].
Continuous glucose monitoring — Continuous glucose monitoring CGM allows determination of peak postprandial glucose levels, mean glucose level, episodes of nocturnal hyperglycemia, and percent time in range for a hour period. We do not routinely use CGM in patients with GDM because of cost and it has not been proven to improve maternal or fetal outcome, but few trials have been performed.
When CGM was compared with frequent self-monitoring of blood glucose in a meta-analysis of two small randomized trials, outcomes were similar for both approaches: cesarean birth risk ratio [RR] 0.
There were no perinatal deaths. Larger trials may clarify whether the favorable trends that were observed are real. Although use of CGM has no clear advantages for most patients, it may be considered in patients who cannot consistently check fingerstick glucose levels and are willing to wear a device.
In addition, some patients choose to use CGM because they want the detailed information about their glucose levels that it provides. Cost may be a barrier to use. Glucose target — Glucose targets vary among countries and the precise target for optimum maternal, fetal, and newborn outcome is not well-established [ 42 ].
In the United States, the American Diabetes Association ADA and the American College of Obstetricians and Gynecologists ACOG recommend the following upper limits for glucose levels, with insulin therapy initiated if they are exceeded, but acknowledge that these thresholds have been extrapolated from recommendations proposed for pregnant patients with preexisting diabetes [ 24,43 ]:.
These targets are well above the mean glucose values in pregnant people without diabetes described in a literature review of studies of the normal hour glycemic profile of pregnant people [ 44 ].
These levels were derived from measurements on whole blood, plasma, self-monitored capillary glucose measurements, or tissue fluid CGM. Although glucose levels in whole blood, plasma, and interstitial fluid differ, there was some consistency in the results.
Glycated hemoglobin — A1C may be a helpful ancillary test in assessing glycemic management during pregnancy [ 45,46 ]. It is not clear whether or how often it should be monitored in patients with GDM with glucose levels are in the target range.
If measured and there is a discrepancy between the A1C and glucose values, then potential causes should be investigated. High-quality normative data for A1C in each trimester are not available.
A1C values tend to be lower in pregnant compared with nonpregnant people [ 47 ] because the average blood glucose concentration is approximately 20 percent lower in pregnant people, and in the first half of pregnancy, there is a rise in red cell mass and a slight increase in red blood cell turnover [ 48,49 ].
Other factors that have been reported to affect A1C values include race although it is not clear whether the higher A1C levels observed in Black persons compared with White persons are due to differences in glucose levels or racial differences in the glycation of hemoglobin [ 50 ] and iron status chronic iron deficiency anemia increases A1C, treatment of iron deficiency anemia with iron lowers A1C.
Sources of variation in A1C levels are discussed in detail separately. See "Measurements of chronic glycemia in diabetes mellitus", section on 'Glycated hemoglobin A1C '.
Episodes of physiological ketonemia and ketonuria are not uncommon in pregnancy and can occur with hypocaloric diets [ 53 ]. Studies have reported inconsistent findings regarding a potential association between ketonuria and impaired cognitive outcome in offspring [ ]. Goal — The goal of pharmacotherapy is to manage glucose levels so that the majority are no higher than the upper limit of the target range, without inducing any episodes of hypoglycemia.
: Hyperglycemia in pregnancy| What is diabetes? | Some authors have reported increased rates of Hyperg,ycemia and differences Collagen for Healthy Teeth outcomes Antioxidant supplements for mood enhancement to fetal Electrolyte Regulation, with Adaptogen herbal medicine worse Hypeeglycemia for male newborns in GDM pregnancies [ HyperglyycemiaAdaptogen herbal medicine ]. Hyperlgycemia and permissions Open Access This article is licensed under a Creative Commons Attribution 4. You may opt-out of email communications at any time by clicking on the unsubscribe link in the e-mail. Obstet Gynecol ; e People with gestational diabetes are more likely to develop type 2 diabetes in later life. This finding reveals how maternal health status is the determinant of health of the newborn. |
| Type 1 or Type 2 Diabetes and Pregnancy | CDC | This causes Collagen for Healthy Teeth to form Restoring healthy radiance the baby grows jn large. Collagen for Healthy Teeth patients with mildly Hyperglycsmia glucose levels who do not Hypeglycemia standard criteria for GDM may Hyeprglycemia more favorable pregnancy outcomes if treated since the relationship between glucose levels and adverse pregnancy outcomes such as macrosomia exists continuously across the spectrum of increasing glucose levels [ ]. See 'Oral hypoglycemic agents' above. Fetal movement counting. A lunchtime dose of rapid-acting insulin may be added if there is continued postprandial lunch hyperglycemia. |
| Diabetes During Pregnancy | The overall prevalence of HIP was found to be However, it was thought that using FPG to potentially identify pregnancies at very low risk for GDM and for adverse outcomes requires further evaluation. Diabetes and Pregnancy: Gestational diabetes. Pregnancies After the Diagnosis of Mild Gestational Diabetes Mellitus and Risk of Cardiometabolic Disorders. Maternal factors associated with hyperglycemia in pregnancy and perinatal outcomes: a Brazilian reference center cohort study. |
| Gestational diabetes - Symptoms & causes - Mayo Clinic | If you're planning to get pregnant, losing extra weight beforehand may help you have a healthier pregnancy. Focus on making lasting changes to your eating habits that can help you through pregnancy, such as eating more vegetables and fruits. Don't gain more weight than recommended. Gaining some weight during pregnancy is typical and healthy. But gaining too much weight too quickly can increase your risk of gestational diabetes. Ask your health care provider what a reasonable amount of weight gain is for you. By Mayo Clinic Staff. Apr 09, Show References. American College of Obstetricians and Gynecologists. Practice Bulletin No. Diabetes and Pregnancy: Gestational diabetes. Centers for Disease Control and Prevention. Accessed Dec. Gestational diabetes. National Institute of Diabetes and Digestive and Kidney Diseases. Gestational diabetes mellitus. Mayo Clinic; Durnwald C. Gestational diabetes mellitus: Screening, diagnosis, and prevention. Accessed Nov. American Diabetes Association. Standards of medical care in diabetes — Diabetes Care. Mack LR, et al. Gestational diabetes — Diagnosis, classification, and clinical care. Obstetrics and Gynecology Clinics of North America. Tsirou E, et al. Guidelines for medical nutrition therapy in gestational diabetes mellitus: Systematic review and critical appraisal. Journal of the Academy of Nutrition and Dietetics. Rasmussen L, et al. Diet and healthy lifestyle in the management of gestational diabetes mellitus. Caughey AB. Gestational diabetes mellitus: Obstetric issues and management. Castro MR expert opinion. Mayo Clinic. Associated Procedures. Glucose challenge test. Glucose tolerance test. Labor induction. Show the heart some love! Give Today. Help us advance cardiovascular medicine. Find a doctor. Explore careers. Sign up for free e-newsletters. About Mayo Clinic. About this Site. Contact Us. Health Information Policy. Media Requests. News Network. Price Transparency. Medical Professionals. Clinical Trials. Mayo Clinic Alumni Association. Refer a Patient. Executive Health Program. International Business Collaborations. Supplier Information. Admissions Requirements. Degree Programs. Research Faculty. International Patients. Financial Services. Community Health Needs Assessment. Financial Assistance Documents — Arizona. Financial Assistance Documents — Florida. Financial Assistance Documents — Minnesota. Follow Mayo Clinic. Get the Mayo Clinic app. The exact reason stillbirths happen with diabetes is not known. The risk of stillbirth goes up in women with poor blood glucose control and with blood vessel changes. Birth defects. Birth defects are more likely in babies of diabetic mothers. Some birth defects are serious enough to cause stillbirth. Birth defects usually occur in the first trimester of pregnancy. Babies of diabetic mothers may have major birth defects in the heart and blood vessels, brain and spine, urinary system and kidneys, and digestive system. This is the term for a baby that is much larger than normal. All of the nutrients the baby gets come directly from the mother's blood. If the mother's blood has too much sugar, the pancreas of the baby makes more insulin to use this glucose. This causes fat to form and the baby grows very large. Birth injury. Birth injury may occur due to the baby's large size and difficulty being born. The baby may have low levels of blood glucose right after delivery. This problem occurs if the mother's blood glucose levels have been high for a long time. After delivery, the baby continues to have a high insulin level, but no longer has the glucose from the mother. This causes the newborn's blood glucose level to get very low. The baby's blood glucose level is checked after birth. If the level is too low, the baby may need glucose in an IV. Trouble breathing respiratory distress. Too much insulin or too much glucose in a baby's system may keep the lungs from growing fully. This can cause breathing problems in babies. This is more likely in babies born before 37 weeks of pregnancy. Women with Type 1 or Type 2 diabetes are at increased risk for preeclampsia during pregnancy. To lower the risk, they should take low-dose aspirin 60 to mg a day from the end of the first trimester until the baby is born. Not all types of diabetes can be prevented. Type 1 diabetes usually starts when a person is young. Type 2 diabetes may be avoided by losing weight. Healthy food choices and exercise can also help prevent Type 2 diabetes. Special testing and monitoring of the baby may be needed for pregnant diabetics, especially those who are taking insulin. This is because of the increased risk for stillbirth. These tests may include:. Fetal movement counting. This means counting the number of movements or kicks in a certain period of time, and watching for a change in activity. This is an imaging test that uses sound waves and a computer to create images of blood vessels, tissues, and organs. Ultrasounds are used to view internal organs as they function, and to look at blood flow through blood vessels. Nonstress testing. Biophysical profile. This is a measure that combines tests such as the nonstress test and ultrasound to check the baby's movements, heart rate, and amniotic fluid. Doppler flow studies. This is a type of ultrasound that uses sound waves to measure blood flow. A baby of a diabetic mother may be delivered vaginally or by cesarean section. It will depend on your health, and how much your pregnancy care provider thinks the baby weighs. Your pregnancy care provider may advise a test called amniocentesis in the last weeks of pregnancy. This test takes out some of the fluid from the bag of waters. Testing the fluid can tell if the baby's lungs are mature. The lungs mature more slowly in babies whose mothers have diabetes. If the lungs are mature, the healthcare provider may advise induced labor or a cesarean delivery. Diabetes is a condition in which the body can't produce enough insulin, or it can't use it normally. |
die Interessante Variante
Ich denke, dass Sie den Fehler zulassen. Ich kann die Position verteidigen. Schreiben Sie mir in PM, wir werden reden.
Wohl, ich werde mit Ihrer Phrase zustimmen